Beijing World Trade Dongrui Pharmaceutical Technology

Beijing World Trade Dongrui Pharmaceutical Technology is a China-based pharmaceutical research and development company that operates primarily as a Contract Research Organization (CRO). Established in 2005 and headquartered in Beijing, the firm specializes in the development of high-end generic drugs, consistency evaluation services, and innovative drug delivery technologies. The company provides a comprehensive suite of services ranging from pharmaceutical formulation and analytical research to clinical trial management and technology transfer. With a focus on therapeutic areas such as cardiovascular health, metabolic diseases, and oncology, Beijing World Trade Dongrui supports pharmaceutical manufacturers in meeting stringent regulatory standards. Their expertise is particularly noted in the field of complex formulations, including sustained-release and targeted delivery systems.